Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends That Matter for Cancer Care

Posted by Angela Maas on Apr 11, 2019

new-blog-image-access

With more targeted and effective therapies launching to treat a variety of cancers, much of the focus has been not only on their efficacy but their costs, particularly to payers. A recent report from the physician perspective highlights their impact as far as cost on not only those stakeholders but also the patients they serve, AIS Health reported.

The Association of Community Cancer Centers released its 2018 Trending Now in Cancer Care Survey in February. Responding to the survey were 205 individuals from community cancer centers, academic centers, teaching hospitals and independent practices.
 
Leading the top threats to future growth were payer reimbursement requirements and "cost of drugs and/or new treatment modalities," both at 48% among those categories ranked among the top five threats. Those were followed by "uncertainties in drug pricing reform policies," at 40%.

When it came to patients, 49% of respondents said they had had a patient refuse treatment due to financial concerns over the past year, with 32% responding that they were not sure if that had occurred. In addition, 79% of respondents said they were "very" or "somewhat" concerned about patients refusing care due to financial worries.
 
Trends 04112019


Subscribe to the MMIT blog for more pharma, provider, and payer perspectives on key topics that affect the healthcare network.

Subscribe for Weekly Perspectives

Topics: Industry Trends, Data & Analytics